Carregant...
Experimental Agents for the Treatment of Atherosclerosis: New Directions
Cardiovascular and related metabolic disorders constitute a worldwide health challenge. Atherosclerosis is a chronic inflammatory condition based on both dyslipidemia and inflammation. Therefore, even when dyslipidemia is controlled, the risk of atherosclerosis remains. Among the most efficient infl...
Guardat en:
| Publicat a: | J Exp Pharmacol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7901406/ https://ncbi.nlm.nih.gov/pubmed/33633471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S265642 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|